India to China: Clopidogrel Export Trade Route

The India to China Clopidogrel corridor is one of India's established pharmaceutical export routes, with 104 shipments documented worth a combined $8.2M USD. The route is dominated by DR.REDDY'S LABORATORIES LTD, which alone accounts for roughly 31% of all export value, reflecting the consolidated nature of India's clopidogrel manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $78.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with clopidogrel's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 19.8%, placing it at rank #9 among India's top clopidogrel export destinations globally.

On the import side, key buyers of Indian clopidogrel in China include SHENZHEN FONCOO PHARMACEUTICAL CO, LONGNAN FONCOO PHARMACEUTICAL CO, SHENZHEN FONCOO PHARMACEUTICAL CO., and 22 others. SHENZHEN FONCOO PHARMACEUTICAL CO is the single largest importer with 19 shipments valued at $1.7M USD.

India's clopidogrel exports to China are driven primarily by a handful of large-scale manufacturers. DR.REDDY'S LABORATORIES LTD with 32 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in China benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — DR.REDDY'S LABORATORIES LTD, DR REDDYS LABORATORIES LIMITED, DR.REDDY'S LABORATORIES LTD — together account for 68% of total trade value on this route. The average shipment value of $78.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as plagril 75mg clopidogrel bisulfate tablets 75mg 21 s pack and plagril 75 mg (clopidogrel bisulfate tab, suggesting that buyers in China tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SHENZHEN FONCOO PHARMACEUTICAL CO is the largest importer with 19 shipments worth $1.7M USD — representing 20% of all clopidogrel imports from India on this route. A total of 25 buyers are active on this corridor.